Search for: "AVANIR Pharmaceuticals"
AVANIR Pharmaceuticals Announces Hiring of Michael McFadden as Vice President of U.S. Sales and Managed Markets
HSMN NewsFeed,
3 May 2010:
Biopharmaceuticals, Neurology, Personnel
[AVANIR Pharmaceuticals]
|
David J. Mazzo, Ph.D., Joins Regado Biosciences as President and CEO
HSMN NewsFeed,
4 Aug 2008:
Biopharmaceuticals, Personnel
[Regado Biosciences]
|
AVANIR Granted Special Protocol Assessment (SPA) From FDA for Confirmatory Phase III Trial of Zenvia in Patients With PBA
HSMN NewsFeed,
8 Oct 2007:
Biopharmaceuticals, Neurology
[AVANIR Pharmaceuticals, Zenvia, dextromethorphan, quinidine, pseudobulbar affect]
|
AVANIR Pharmaceuticals Completes Sale Of FazaClo
HSMN NewsFeed,
6 Aug 2007:
Biopharmaceuticals, Acquisitions
[AVANIR Pharmaceuticals, Azur Pharma, FazaClo, clozapine]
|
Azur Pharma Announces the Acquisition of FazaClo for $42 Million Plus Contingent Milestones
HSMN NewsFeed,
3 Jul 2007:
Biopharmaceuticals, Acquisitions
[Azur Pharma, Avanir Pharmaceuticals, FazaClo, clozapine]
|
AVANIR Pharmaceuticals Announces Sale of FazaClo to Fund Continued Development of Zenvia
HSMN NewsFeed,
3 Jul 2007:
Biopharmaceuticals
[AVANIR Pharmaceuticals, FazaClo, clozapine, Azur Pharma]
|
AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic Peripheral Neuropathic Pain at International Congress on Neuropathic Pain
HSMN NewsFeed,
8 Jun 2007:
Biopharmaceuticals
[AVANIR Pharmaceuticals, Zenvia, neuropathic pain, DPN]
|
AVANIR Receives FDA Approval for New Formulation of Currently Marketed Antipsychotic Drug FazaClo
HSMN NewsFeed,
31 May 2007:
Biopharmaceuticals, FDA
[AVANIR Pharmaceuticals, FazaClo, clozapine]
|
Avanir Pharmaceuticals Announces Positive Results of Phase III Study for Zenvia in Diabetic Neuropathic Pain
HSMN NewsFeed,
18 Apr 2007:
Biopharmaceuticals
[Avanir Pharmaceuticals, Zenvia, dextromethorphan, quinidine, Neuropathic Pain]
|
Amarin Appoints Paul F. Duffy to New Position of President - U.S. Commercial Operations
HSMN NewsFeed,
3 Apr 2007:
Biopharmaceuticals, Personnel
[Amarin Corp]
|
AVANIR Pharmaceuticals Appoints New Chief Executive Officer
HSMN NewsFeed,
14 Mar 2007:
Biopharmaceuticals, Personnel
[ AVANIR Pharmaceuticals]
|
AVANIR Pharmaceuticals Summarizes Outcome of FDA Meeting on Zenvia NDA
HSMN NewsFeed,
28 Feb 2007:
Biopharmaceuticals, FDA
[AVANIR Pharmaceuticals, Zenvia, IEED, involuntary emotional expression disorder]
|
AVANIR Pharmaceuticals Hires Martin J. Sturgeon as Vice President and Chief Accounting Officer
HSMN NewsFeed,
12 Feb 2007:
Biopharmaceuticals, Personnel
[AVANIR Pharmaceuticals]
|
AVANIR Receives FDA Approvable Letter for New Formulation of Currently Marketed Antipsychotic Drug FazaClo
HSMN NewsFeed,
30 Jan 2007:
Biopharmaceuticals, FDA
[AVANIR Pharmaceuticals, FazaClo, clozapine]
|
Harold F. Oberkfell Succeeds Steven A. Elms as Chairman of Adams Respiratory Therapeutics
HSMN NewsFeed,
16 Jan 2007:
Biopharmaceuticals, Personnel
[Adams Respiratory Therapeutics]
|
ADVENTRX Announces Appointment of Veteran Finance and Biotech Industry Executive Gregory P. Hanson as Chief Financial Officer
HSMN NewsFeed,
20 Dec 2006:
Biopharmaceuticals, Personnel
[ADVENTRX Pharmaceuticals]
|
Kemia Announces Appointment of Senior VP of Business Development
HSMN NewsFeed,
13 Dec 2006:
Biopharmaceuticals, Personnel
[ Kemia]
|
AVANIR Receives FDA Approvable Letter for Zenvia for the Treatment of Involuntary Emotional Expression Disorder
HSMN NewsFeed,
31 Oct 2006:
Biopharmaceuticals, FDA
[AVANIR Pharmaceuticals, Zenvia, Neurodex, IEED]
|
Momenta Pharmaceuticals Announces Appointment of Craig A. Wheeler as Chief Executive Officer
HSMN NewsFeed,
22 Aug 2006:
Biopharmaceuticals, Personnel
[Momenta Pharmaceuticals]
|
AVANIR Pharmaceuticals Hires Theresa Hope-Reese as Vice President of Human Resources
HSMN NewsFeed,
7 Aug 2006:
Biopharmaceuticals, Personnel
[AVANIR Pharmaceuticals]
|
AVANIR Completes the Acquisition of Alamo Pharmaceuticals
HSMN NewsFeed,
24 May 2006:
Biopharmaceuticals, Mergers & Acquisitions
[AVANIR Pharmaceuticals, Alamo Pharmaceuticals, FazaClo, clozapine]
|
AVANIR Announces the Intended Acquisition of a Private Specialty Pharmaceutical Company
HSMN NewsFeed,
23 May 2006:
Biopharmaceuticals, Mergers & Acquisitions
[AVANIR Pharmaceuticals, Alamo Pharmaceuticals, FazaClo, clozapine]
|
Dr. Gerald J. Yakatan Appointed CEO of Cobalis Corp.
HSMN NewsFeed,
11 May 2006:
Biopharmaceuticals, Personnel
[Cobalis]
|
AVANIR Pharmaceuticals Hires Michael J. Puntoriero to Serve as Senior Vice President of Finance and Chief Financial Officer
HSMN NewsFeed,
8 May 2006:
Biopharmaceuticals, Personnel
[AVANIR Pharmaceuticals]
|
AVANIR Announces Neurodex Phase III Trial Results Published in Annals of Neurology
HSMN NewsFeed,
28 Apr 2006:
Biopharmaceuticals, Neurology
[AVANIR Pharmaceuticals, Neurodex, IEED, pseudobulbar affect, emotional lability]
|
AVANIR's Neurodex NDA Accepted with Priority Review for Involuntary Emotional Expression Disorder
HSMN NewsFeed,
4 Apr 2006:
Biopharmaceuticals, Neurology, FDA
[AVANIR Pharmaceuticals, Neurodex, IEED, pseudobulbar affect]
|
AVANIR Pharmaceuticals Hires Matthew R. Ruth as Vice President of Sales
HSMN NewsFeed,
1 Mar 2006:
Biopharmaceuticals, Personnel
[AVANIR Pharmaceuticals]
|
AVANIR Submits Expanded Neurodex New Drug Application for the Treatment of Involuntary Emotional Expression Disorder
HSMN NewsFeed,
30 Jan 2006:
Biopharmaceuticals, FDA
[AVANIR Pharmaceuticals, Neurodex, dextromethorphan, quinidine]
|
AVANIR Licenses Docosanol 10% Cream in Japan
HSMN NewsFeed,
11 Jan 2006:
Biopharmaceuticals, Licensing, Distribution
[AVANIR Pharmaceuticals, docosanol]
|
AVANIR Pharmaceuticals Hires Randall E. Kaye, M.D. as Vice President of Medical Affairs
HSMN NewsFeed,
11 Jan 2006:
Biopharmaceuticals, Personnel
[AVANIR Pharmaceuticals]
|
|
|
Public
Feeds 
Full text >>
